BOSTON PRIVATE FINANCIAL HOLDINGS INC - FORM 8-K - EX-11

Attached files

file	filename
8-K - BOSTON PRIVATE FINANCIAL HOLDINGS INC	tarpwarrant020711.htm

EXECUTION VERSION

2,887,500 Warrants

BOSTON PRIVATE FINANCIAL HOLDINGS, INC.

UNDERWRITING AGREEMENT

February 1, 2011

Deutsche Bank Securities Inc.

As Representative of the

several Underwriters

c/o Deutsche Bank Securities Inc.

60 Wall Street, 4th Floor

New York, New York 10005

Ladies and Gentlemen:

The United States Department of the Treasury (the “Selling Security Holder”) proposes

to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto, for whom

you are acting as representative (the “Representative”), an aggregate of up to 2,887,500 warrants

(the “Warrants”) of Boston Private Financial Holdings, Inc., a Massachusetts corporation (the

“Company”), representing the right to purchase an aggregate of up to that same number of shares

(the “Warrant Shares”) of the Company’s common stock, $1.00 par value (the “Common

Stock”). The respective maximum amounts of the Warrants to be so purchased by the several

Underwriters are set forth opposite their names in Schedule I hereto.

As the Representative, you have advised the Company and the Selling Security Holder that

(a) you are authorized to enter into this Agreement on behalf of the several Underwriters, and (b) the

several Underwriters are willing, acting severally and not jointly, to purchase the numbers of

Warrants set forth opposite their respective names in Schedule I. If Deutsche Bank Securities Inc.

is the sole Underwriter named in Schedule I, then all references in this Agreement to the

“Representative” and the “Underwriters” shall be deemed to be references to Deutsche Bank

Securities Inc.

In consideration of the mutual agreements contained herein and of the interests of the

parties in the transactions contemplated hereby, the parties hereto agree as follows:

1.REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE SELLING SECURITY

HOLDER.


(a)	The Company represents and warrants to each of the Underwriters as follows:


(i)	A registration statement on Form S-3 (File No. 333-171599) with respect

to the Warrants and the Warrant Shares, including a form of prospectus, has been

prepared by the Company in conformity with the requirements of the Act, and the rules

and regulations of the Securities and Exchange Commission (the “Commission”)

thereunder and has been filed by the Company with the Commission not earlier than three

years prior to the date hereof. The Company and the transactions contemplated by this

Agreement meet the requirements and comply with the conditions for the use of a

registration statement on Form S-3. Copies of such registration statement, including any

amendments thereto, the Base Prospectus (as defined below) as supplemented by any

preliminary prospectus (including any preliminary prospectus supplement) relating to the

Warrants and Warrant Shares filed or to be filed with the Commission pursuant to Rule

424(b) under the Act and including the documents incorporated in the Base Prospectus by

reference (a “Preliminary Prospectus”) and the exhibits, financial statements and

schedules to such registration statement, in each case as finally amended and revised,

have heretofore been made available by the Company to you. Such registration

statement, together with any registration statement filed by the Company pursuant to

Rule 462(b) under the Securities Act of 1933, as amended (the “Act”), is herein referred

to as the “Registration Statement,” which shall be deemed to include all information

omitted therefrom in reliance upon Rules 430A, 430B or 430C under the Act and

contained in the Prospectus referred to below. Such registration statement was declared

effective by the Commission on January 28, 2011, and no post-effective amendment to

the Registration Statement has been filed as of the date of this Agreement. The base

prospectus filed as part of such registration statement, in the form in which it has most

recently been filed with the Commission on or prior to the date of this Agreement, is

hereinafter called the “Base Prospectus.” “Prospectus” means the form of prospectus

relating to the Warrants and the Warrant Shares first filed with the Commission pursuant

to and within the time limits described in Rule 424(b) under the Act and in accordance

with Section 4(a)(i)(A) of this Agreement. Any reference herein to the Registration

Statement, the Base Prospectus, any Preliminary Prospectus or to the Prospectus or to any

amendment or supplement to any of the foregoing documents shall be deemed to refer to

and include any documents incorporated by reference therein, and, in the case of any

reference herein to the Prospectus, also shall be deemed to include any documents

incorporated by reference therein, and any supplements or amendments thereto, filed with

the Commission after the date of filing of the Prospectus under Rule 424(b) under the Act

and prior to the termination of the offering of the Warrants by the Underwriters.


(ii)	As of the Applicable Time (as defined below) and as of the Closing Date

(as defined below), neither (i) the General Use Free Writing Prospectus(es) (as defined

below) issued at or prior to the Applicable Time, the Statutory Prospectus (as defined

below) and the information included on Schedule II hereto, all considered together

(collectively, the “General Disclosure Package”), nor (ii) any individual Limited Use

Free Writing Prospectus (as defined below), when considered together with the General

Disclosure Package, included or will include any untrue statement of a material fact or

omitted or will omit to state a material fact necessary in order to make the statements

therein, in the light of the circumstances under which they were made, not misleading;

provided, however, that the Company makes no representations or warranties as to

information contained in or omitted from any Issuer Free Writing Prospectus (as defined

below), in reliance upon, and in conformity with, written information furnished to the

Company by the Selling Security Holder or by or through the Representative on behalf of

the Underwriters specifically for use therein, it being understood and agreed that the only

such information supplied by or through the Representative is that described in Section

13 herein. As used in this subsection and elsewhere in this Agreement:

“Applicable Time” means the time at which bids submitted to the auction agent

(the “Auction Agent”) in connection with the auction relating to the Warrants (the

“Auction”) become irrevocable and may no longer be withdrawn, as set forth in the

Preliminary Prospectus (including any extension of such deadline).

“Statutory Prospectus” means the Base Prospectus, as amended and supplemented

immediately prior to the Applicable Time, including any document incorporated by

reference therein and any preliminary prospectus supplement or prospectus supplement

deemed to be a part thereof.

“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as

defined in Rule 433 under the Act, relating to the Warrants or the Warrant Shares in the

form filed or required to be filed with the Commission or, if not required to be filed, in the

form retained in the Company’s records pursuant to Rule 433(g) under the Act.

“General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus

that is identified on Schedule III to this Agreement.

“Limited Use Free Writing Prospectus” means any Issuer Free Writing Prospectus

that is not a General Use Free Writing Prospectus.


(iii)	The Company (A) has been duly organized and is validly existing as a

corporation in good standing under the laws of the jurisdiction of its incorporation, (B) is

duly registered as a bank holding company under the Bank Holding Company Act of

1956, as amended, and (C) has corporate power and authority to own or lease its

properties and conduct its business as described in the Registration Statement, the

General Disclosure Package and the Prospectus. The Company is duly qualified to

transact business and is in good standing in each jurisdiction in which its ownership or

lease of properties or the conduct of its business requires such qualification, except where

the failure to be so qualified or in good standing would not, individually or in the

aggregate, reasonably be expected to either (i) have a material adverse effect on the

business, management, results of operations, or financial condition of the Company and

of its subsidiaries taken as a whole, or (ii) prevent the consummation of the transactions

contemplated hereby (the occurrence of any such effect or any such prevention described

in the foregoing clauses (i) and (ii) being referred to as a “Material Adverse Effect”).


(iv)	Each of the significant subsidiaries (as defined in Rule 1-02 of Regulation

S-X of the Commission) of the Company are listed in Exhibit A hereto (each a

“Subsidiary” and, collectively, the “Subsidiaries”), each has been duly organized and is

validly existing as a corporation, banking corporation or association, or other type of

entity, as applicable, in good standing under the laws of the jurisdiction of its

incorporation, establishment or formation, as applicable, with corporate, limited liability

company or other organizational power and authority to own or lease its properties and

conduct its business as described in the Registration Statement, the General Disclosure

Package and the Prospectus. Each Subsidiary is duly qualified to transact business and is

in good standing in each jurisdiction in which its ownership or lease of properties or the

conduct of its business requires such qualification, other than where the failure to be so

qualified would not reasonably be expected to have a Material Adverse Effect. The

outstanding shares of capital stock of each of the Subsidiaries have been duly authorized

and validly issued, are fully paid and non-assessable and, other than as described in the

General Disclosure Package and the Prospectus, are owned by the Company or the

Subsidiaries free and clear of all liens, encumbrances, equities and claims. Other than as

described in the General Disclosure Package and the Prospectus, no options, warrants or

other rights to purchase, agreements or other obligations to issue or other rights to

convert any obligations into shares of capital stock or ownership interests in the

Subsidiaries are outstanding.


(v)	The Warrants have been duly authorized and validly issued and constitute

valid and binding obligations of the Company enforceable in accordance with their terms,

and no preemptive rights of stockholders exist with respect to any Warrant Shares

issuable upon exercise of the Warrants. The Warrants conform in all material respects to

the description thereof set forth in the Registration Statement, the General Disclosure

Package and the Prospectus. The form of certificate for the Warrants conforms to the

corporate law of the jurisdiction of the Company’s incorporation and to any requirements

of the Company’s organizational documents. Neither the filing of the Registration

Statement nor the offering or sale of the Warrants as contemplated by this Agreement

gives rise to any rights, other than those which have been waived or satisfied, for or

relating to the registration of any Warrants or Warrant Shares.


(vi)	The Warrant Shares have been duly authorized, and, when issued and

delivered upon exercise of the Warrants against payment of the exercise price with

respect to the Warrants, will be fully paid and non-assessable and will not be subject to

any preemptive or similar rights. The Warrant Shares will conform in all material

respects to the description thereof set forth in the Registration Statement, the General

Disclosure Package and the Prospectus. The form of certificates for the Warrant Shares

conforms to the corporate law of the jurisdiction of the Company’s incorporation and to

any requirements of the Company’s organizational documents. The Company has duly

authorized the reservation of the Warrant Shares.


(vii)	The outstanding shares of capital stock of the Company have been duly

authorized and validly issued and are fully paid and non-assessable.


(viii)	Except as described in or contemplated by the Registration Statement, the

General Disclosure Package and the Prospectus, there are no outstanding rights

(including, without limitation, pre-emptive rights), warrants or options to acquire from

the Company, or instruments convertible or exchangeable for, any shares of capital stock

or other equity interest in the Company or any of the Subsidiaries, or any contract,

commitment, agreement, understanding or arrangement of any kind to which the

Company or any of the Subsidiaries is a party relating to the issuance of any capital stock

of the Company or any such Subsidiary, any such convertible or exchangeable securities

or any such rights, warrants or options, except as may have been granted by the Company

pursuant to employee awards and employee benefit plans in the ordinary course of

business and consistent with past practice.


(ix)	The Commission has not issued an order preventing or suspending the use

of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus

relating to the proposed offering of the Warrants, and no proceeding for that purpose or

pursuant to Section 8A of the Act has been instituted or, to the Company’s knowledge,

threatened by the Commission. The Registration Statement contains, and the Prospectus

and any amendments or supplements thereto will contain, all statements required to be

stated therein by, and will conform in all material respects to, the requirements of the Act

and the Rules and Regulations (as defined below). The documents incorporated, or to be

incorporated, by reference in the General Disclosure Package or the Prospectus

conformed or, at the time filed with the Commission, will conform, in all material

respects to the requirements of the Securities Exchange Act of 1934 (“Exchange Act”) or

the Act, as applicable, and the rules and regulations of the Commission thereunder (the

“Rules and Regulations”), and such documents do not contain, and will not contain, any

untrue statement of a material fact and do not omit, or will not omit, to state a material

fact required to be stated therein or necessary to make the statements therein, in light of

the circumstances under which they were made, not misleading. The Registration

Statement and any amendment thereto do not contain, and will not contain, any untrue

statement of a material fact and do not omit, and will not omit, to state a material fact

required to be stated therein or necessary to make the statements therein not misleading;

and the Prospectus and any amendments and supplements thereto will not contain any

untrue statement of a material fact, and will not omit to state a material fact necessary in

order to make the statements therein, in the light of the circumstances under which they

were made, not misleading; provided, however, that the Company makes no

representations or warranties as to information contained in or omitted from the

Registration Statement or the Prospectus, or any such amendment or supplement, in

reliance upon, and in conformity with, written information furnished to the Company by

the Selling Security Holder or by or through the Representative on behalf of the

Underwriters specifically for use therein, it being understood and agreed that the only

such information furnished by or through the Representative is that described in Section

13 herein.

(x)Each Issuer Free Writing Prospectus, as of its issue date and at all

subsequent times through the completion of the public offer and sale of the Warrants or

until any earlier date that the Company notified or notifies the Representative, did not,

does not and will not include any information that conflicted, conflicts or will conflict

with the information contained in the Registration Statement or the Prospectus in any

material respect, including any document incorporated by reference therein and any

prospectus supplement deemed to be a part thereof that has not been superseded or

modified.

(xi)The Company has not, directly or indirectly, distributed and will not prior

to the Closing Date distribute any offering material in connection with the offering and

sale of the Warrants other than any Preliminary Prospectus, the Prospectus and other

materials, if any, permitted under the Act and consistent with Section 4(a)(ii) below. The

Company will file with the Commission all Issuer Free Writing Prospectuses in the time

required under Rule 433(d) under the Act.

(xii)The consolidated financial statements of the Company and the

Subsidiaries, together with related notes and schedules as set forth or incorporated by

reference in the Registration Statement, the General Disclosure Package and the

Prospectus, comply as to form in all material respects with the requirements of the Act

and the Exchange Act and present fairly the consolidated financial position and the

results of operations and cash flows of the Company and the Subsidiaries, at the indicated

dates and for the indicated periods. Such financial statements and related schedules have

been prepared in accordance with generally accepted principles of accounting (“GAAP”),

consistently applied throughout the periods involved, except as disclosed therein, and all

adjustments necessary for a fair presentation of results for such periods have been made.

The summary and selected consolidated financial and statistical data included or

incorporated by reference in the Registration Statement, the General Disclosure Package

and the Prospectus present fairly the information shown therein and such data have been

compiled on a basis consistent with the financial statements presented therein and the

books and records of the Company. Any disclosures contained in the Registration

Statement, the General Disclosure Package and the Prospectus regarding “non-GAAP

financial measures” (as such term is defined by the Rules and Regulations) comply in all

material respects with Regulation G under the Exchange Act and Item 10 of Regulation

S-K under the Act, to the extent applicable.


(xiii)	Each of KPMG LLP (the “Accountants”), who have certified certain

financial statements of the Company and its subsidiaries, and Hacker, Johnson & Smith

PA, who have certified certain financial statements of Gibraltar Private Bank & Trust

Company (“Gibraltar”), each of which financial statements have been or will be filed

with the Commission as part of, or incorporated by reference in, the Registration

Statement, the General Disclosure Package and the Prospectus, is an independent

registered public accounting firm with respect to the Company and the Subsidiaries or

Gibraltar, as applicable, within the meaning of the Act, the applicable Rules and

Regulations and the rules and regulations of the Public Company Accounting Oversight

Board (United States) (the “PCAOB”).


(xiv)	Except as disclosed in the Registration Statement, the General Disclosure

Package and the Prospectus, neither the Company nor any of the Subsidiaries is aware of

(i) any material weakness in its internal control over financial reporting as of or since the

date of the most recent audited financial statements incorporated by reference therein or

(ii) any change in internal control over financial reporting that has materially affected, or

is reasonably likely to materially affect, the Company’s internal control over financial

reporting as of or since the date of the most recent unaudited interim financial statements

incorporated by reference therein.


(xv)	Solely to the extent that the Sarbanes-Oxley Act of 2002, as amended, and

the rules and regulations promulgated by the Commission and the Exchange (as defined

below) thereunder (the “Sarbanes-Oxley Act”) are applicable to the Company, there is

and has been no failure on the part of the Company to comply in all material respects

with any provision thereof.


(xvi)	There is no action, suit, claim, proceeding, inquiry or investigation before

any court or governmental agency or otherwise, pending or, to the knowledge of the

Company, threatened against the Company or any of the Subsidiaries that is reasonably

likely to be determined adversely to the Company or any of the Subsidiaries and to result

in a Material Adverse Effect, except as set forth in the Registration Statement, the

General Disclosure Package and the Prospectus.


(xvii)	Since the respective dates as of which information is given in the

Registration Statement, the General Disclosure Package and the Prospectus, as each may

be amended or supplemented, there has not been any material adverse change in or

affecting the business, management, results of operations or financial condition of the

Company and the Subsidiaries taken as a whole.


(xviii)	Neither the Company nor any Subsidiary is, or with the giving of notice or

lapse of time or both would be, (i) in violation of its certificate or articles of organization

or incorporation, by-laws, certificate of formation, limited liability agreement,

partnership agreement or other organizational documents or (ii) in violation of or in

default under any agreement, lease, contract, indenture or other instrument or obligation

material to the conduct of the business of the Company and its Subsidiaries, taken as a

whole, to which it is a party or by which it, or any of its respective properties, is bound

and, solely with respect to this clause (ii), which violation or default would reasonably be

expected to have a Material Adverse Effect. The execution and delivery of this

Agreement and the consummation of the transactions herein contemplated and the

fulfillment of the terms hereof will not conflict with or result in a breach of (i) any of the

terms or provisions of, or constitute a default under, any indenture, mortgage, deed of

trust or other agreement or instrument to which the Company or any Subsidiary is a party

or by which the Company or any Subsidiary or any of their respective properties is

bound, except where such breach or default would not reasonably be expected to result in

a Material Adverse Effect, (ii) the certificate or articles of organization or incorporation

or by-laws of the Company or (iii) any material law, order, rule or regulation, judgment,

order, writ or decree applicable to the Company or any Subsidiary of any court or of any

government, regulatory body or administrative agency or other governmental body

having jurisdiction.


(xix)	The execution and delivery of, and the performance by the Company of its

obligations under, this Agreement has been duly and validly authorized by all necessary

corporate action on the part of the Company, and this Agreement has been duly executed

and delivered by the Company.


(xx)	Any material approval, consent, order, authorization, designation,

declaration or filing by or with any regulatory, administrative or other governmental body

necessary in connection with the execution and delivery by the Company of this

Agreement and the consummation by the Company of the transactions herein

contemplated (except such additional steps as may be required by the Commission, the

Financial Industry Regulatory Authority, Inc. (“FINRA”) or such steps as may be

necessary to qualify the Warrants and the Warrant Shares for public offering by the

Underwriters under state securities or Blue Sky laws) has been obtained or made and is in

full force and effect.


(xxi)	The Company and each of the Subsidiaries hold all licenses, certificates,

consents, orders, approvals, permits and other authorizations from governmental

authorities to lease or own, as the case may be, and to operate, their respective properties

and to carry on their respective businesses, except where the failure to own, possess or

maintain such governmental licenses, certificates, consents, orders, approvals, permits

and other authorizations would not, individually or in the aggregate, reasonably be

expected to result in a Material Adverse Effect.


(xxii)	Neither the Company, nor to the Company’s knowledge, any of its affiliates,

has taken, directly or indirectly, any action designed to cause or result in, or which has

constituted or which might reasonably be expected to constitute, the stabilization or

manipulation of the price of the Warrants or the Warrant Shares to facilitate the sale or

resale of the Warrants excluding, for the avoidance of doubt, any bid for or purchase of

Warrants made pursuant to the process described in the General Disclosure Package.


(xxiii)	Neither the Company nor any of the Subsidiaries is required to register as

an “investment company” within the meaning of such term under the Investment

Company Act of 1940, as amended (the “1940 Act”), and the rules and regulations of the

Commission thereunder.


(xxiv)	The Company and each of the Subsidiaries maintains a system of internal

accounting controls sufficient to provide reasonable assurances that (i) transactions are

executed in accordance with management’s general or specific authorization; (ii)

transactions are recorded as necessary to permit preparation of financial statements in

conformity with GAAP and to maintain accountability for assets; (iii) access to assets is

permitted only in accordance with management’s general or specific authorization; and

(iv) the recorded accountability for assets is compared with existing assets at reasonable

intervals and appropriate action is taken with respect to any differences.


(xxv)	To the best knowledge of the Company, the operations of the Company

and the Subsidiaries are and have been conducted at all times in material compliance with

applicable financial record-keeping and reporting requirements of the Currency and

Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering

statutes and applicable rules and regulations thereunder (collectively, the “Money

Laundering Laws”), and no action, suit or proceeding by or before any court or

governmental agency, authority or body or any arbitrator involving the Company or any

of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the

Company’s knowledge, threatened, which would reasonably be expected to have a

Material Adverse Effect.


(xxvi)	Neither the Company nor, to the Company’s knowledge, any director,

officer, agent, employee or affiliate of the Company is currently subject to any U.S.

sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury

Department (“OFAC”).


(xxvii)	Neither the Company nor any of the Subsidiaries nor, to the knowledge of

the Company, any director, officer, agent, employee or affiliate of the Company or any of

the Subsidiaries is aware of or has taken any action, directly or indirectly, that would

result in a violation by such Persons of the Foreign Corrupt Practices Act of 1977, as

amended, and the rules and regulations thereunder (the “FCPA”), including, without

limitation, making use of the mails or any means or instrumentality of interstate

commerce corruptly in furtherance of an offer, payment, promise to pay or authorization

of the payment of any money, or other property, gift, promise to give, or authorization of

the giving of anything of value to any “foreign official” (as such term is defined in the

FCPA) or any foreign political party or official thereof or any candidate for foreign

political office, in contravention of the FCPA and the Company, its subsidiaries and, to

the knowledge of the Company, its affiliates have conducted their businesses in

compliance with the FCPA and have instituted and maintain policies and procedures

designed to ensure, and which are reasonably expected to continue to ensure, continued

compliance therewith.


(xxviii)	The Common Stock is registered pursuant to Section 12(b) of the

Exchange Act and is listed on the Nasdaq Global Select Market (the “Exchange”), and

the Company has not received any notification that the Commission or the Exchange is

contemplating terminating such registration or listing. The Warrant Shares have been

approved for listing on the Exchange subject to notice of issuance. The Warrants shall be

registered pursuant to Section 12(b) of the Exchange Act prior to the opening of trading

on the day after the day on which the submission deadline for the Auction occurs and

have been approved for listing on the Exchange subject to notice of issuance, and the

Company has not received any notification that the Commission or the Exchange is

contemplating terminating such registration or listing.

(b)The Selling Security Holder represents and warrants as follows:


(i)	The Selling Security Holder now has and at the Closing Date will have

good and marketable title to the Warrants to be sold by it, free and clear of any liens,

encumbrances, equities and claims, and full right, power and authority to effect the sale

and delivery of the Warrants; and upon the delivery of, against payment for, the Warrants

pursuant to this Agreement, and assuming an Underwriter does not have notice of any

adverse claim (within the meaning of the Uniform Commercial Code as in effect in the

State of New York), such Underwriter will acquire good and marketable title thereto, free

and clear of any liens, encumbrances, equities and claims.


(ii)	The Selling Security Holder has full right, power and authority to execute

and deliver this Agreement and to perform its obligations hereunder, and this Agreement

has been duly authorized, executed and delivered by or on behalf of the Selling Security

Holder.


(iii)	No consent, approval or waiver is required under any instrument or

agreement to which the Selling Security Holder is a party or by which the Selling

Security Holder is bound in connection with the offering, sale or purchase by the

Underwriters of any of the Warrants which may be sold by the Selling Security Holder

under this Agreement or the consummation by the Selling Security Holder of any of the

other transactions contemplated hereby.

2.PURCHASE, SALE AND DELIVERY OF THE WARRANTS.


(a)	On the basis of the representations, warranties and covenants herein contained,

and subject to the conditions herein set forth and the Auction procedures described in the

Preliminary Prospectus and the Prospectus, the Selling Security Holder agrees to sell to the

Underwriters and the Underwriters agree to severally and not jointly purchase as set forth in

Schedule I hereto, subject to any decrease pursuant to Section 2(b) once the Clearing Price (as

defined below) has been determined, an aggregate of 2,887,500 Warrants (the “Number of

Offered Warrants”) at a price per Warrant equal to (i) the price per Warrant (the “Clearing

Price”) to be agreed in writing between the Auction Agent and the Selling Security Holder (such

Clearing Price to be determined following the submission deadline for the Auction to be

commenced promptly following the execution of this Agreement), minus (ii) a discount per

Warrant equal to 1.4% of the aggregate Clearing Price of the Warrants; provided that if the

aggregate discount for all Warrants sold would be less than $150,000, the discount percentage

shall be increased such that the aggregate discount is equal to $150,000.


(b)	If the number of Warrants for which bids are received in the Auction is (i) less

than 50% of the Number of Offered Warrants, then no sales of Warrants shall be made pursuant

to this Agreement, (ii) 50% or more but less than 100% of the Number of Offered Warrants, then

the Selling Security Holder may, but shall not be required to, sell at the minimum price in the

Auction (which in such case shall be the Clearing Price for purposes of this Agreement) however

many Warrants it chooses to sell, up to the number of bids received in the Auction and (iii) 100%

or more of the Number of Offered Warrants but the Selling Security Holder determines in its sole

discretion not to sell any Warrants at the Clearing Price and so advises the Representative, then

no sales of Warrants shall be made pursuant to this Agreement. If (x) the Selling Security

Holder chooses to sell any Warrants in the case of subclause (ii) hereof, it shall sell a number of

Warrants equal to at least 50% of the Number of Offered Warrants and (y) if the Selling Security

Holder chooses to sell any Warrants in the case of subclause (iii) hereof, it shall sell 100% of the

Number of Offered Warrants. In the case of subclause (ii) or subclause (iii) hereof, the Selling

Security Holder shall notify the Representative as promptly as practicable after completion of the

Auction of the number of Warrants it will sell pursuant to this Agreement or its decision not to

sell any Warrants, as the case may be.


(c)	Payment for the Warrants to be sold hereunder is to be made in Federal (same

day) funds to an account designated by the Selling Security Holder (or its agent) against delivery

of certificates therefor to the Representative by the Selling Security Holder (or its agent). Such

payment and delivery are to be made through the facilities of The Depository Trust Company at

10:00 a.m., New York time, on February 7, 2011 or at such other time and date not later than five

business days thereafter as the Representative, the Company and the Selling Security Holder

shall agree upon, such time and date being herein referred to as the “Closing Date.” (As used

herein, “business day” means a day on which the Exchange is open for trading and on which

banks in New York are open for business and not permitted by law or executive order to be

closed.)

3.OFFERING BY THE UNDERWRITERS.

It is understood that the several Underwriters plan to make a public offering of the

Warrants pursuant to the Auction promptly following the execution of this Agreement. It is

further understood that you will act as the Representative for the Underwriters in the offering and

sale of the Warrants.

4.COVENANTS OF THE COMPANY AND THE SELLING SECURITY HOLDER.


(a)	The Company covenants and agrees with the several Underwriters that:


(i)	The Company will (A) prepare and timely file with the Commission under

Rule 424(b) (without reliance on Rule 424(b)(8)) under the Act a Prospectus in a form

approved by the Representative containing information previously omitted at the time of

effectiveness of the Registration Statement in reliance on Rules 430A, 430B or 430C

under the Act; and (B) not file any amendment to the Registration Statement or distribute

an amendment or supplement to the General Disclosure Package or the Prospectus (other

than with respect to a document filed with the Commission pursuant to the Exchange Act

which will be incorporated by referenced in the Registration Statement, the Preliminary

Prospectus, and the Prospectus that is not filed to correct a misstatement, an omission or

non-compliance) or document incorporated by reference therein of which the

Representative and the Selling Security Holder shall not previously have been advised

and furnished with a copy or to which the Representative shall have reasonably objected

in writing or which is not in compliance with the Rules and Regulations.


(ii)	The Company will (i) not issue an Issuer Free Writing Prospectus or a

“free writing prospectus” (as defined in Rule 405 under the Act) required to be filed by

the Company with the Commission under Rule 433 under the Act that relates to the

Warrants unless the Representative approves its use in writing prior to first use (each, a

“Permitted Free Writing Prospectus”); provided that the prior written consent of the

Representative hereto shall be deemed to have been given in respect of the Issuer Free

Writing Prospectus(es) included in Schedule III hereto, (ii) treat each Permitted Free

Writing Prospectus as an Issuer Free Writing Prospectus, (iii) comply with the

requirements of Rules 164 and 433 under the Act applicable to any Issuer Free Writing

Prospectus, including the requirements relating to timely filing with the Commission,

legending and record keeping and (iv) not take any action relating to the Warrants that

would result in any Underwriter or the Company being required to file with the

Commission pursuant to Rule 433(d) under the Act a free writing prospectus prepared by

or on behalf of any Underwriter that such Underwriter otherwise would not have been

required to file thereunder.


(iii)	The Company will advise the Representative and the Selling Security

Holder promptly (A) when any post-effective amendment to the Registration Statement

or new registration statement relating to the Warrants or the Warrant Shares shall have

become effective, or any supplement to the Prospectus shall have been filed, (B) of

receipt of any comments to the Registration Statement from the Commission, (C) of any

request of the Commission for amendment of the Registration Statement or for the filing

of a new registration statement or any amendment or supplement to the General

Disclosure Package or the Prospectus or any document incorporated by reference therein

or otherwise deemed to be a part thereof or for any additional information, (D) of the

issuance by the Commission of any stop order suspending the effectiveness of the

Registration Statement or such new registration statement or any order preventing or

suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or

the Prospectus, or of the institution of any proceedings for that purpose or pursuant to

Section 8A of the Act, and (E) of any notice of objection of the Commission to the use of

the Registration Statement or any such new registration statement or any post-effective

amendment thereto pursuant to Rule 401(g)(1) under the Act. The Company will use

reasonable best efforts to prevent the issuance of any such order described in clause (D)

and to obtain as soon as possible the lifting thereof, if issued.


(iv)	The Company agrees to pay the required filing fees to the Commission

relating to the Warrants and the Warrant Shares within the time required by Rule 456(a)

under the Act and otherwise in accordance with Rule 457 under the Act.


(v)	The Company will cooperate with the Representative in endeavoring to

qualify the Warrants and the Warrant Shares for sale under the securities laws of such

jurisdictions as the Representative may reasonably have designated in writing and will

make such applications, file such documents, and furnish such information as may be

reasonably required for that purpose, provided the Company shall not be required to

qualify as a foreign corporation or to file a general consent to service of process in any

jurisdiction where it is not now so qualified or required to file such a consent. The

Company will, from time to time, prepare and file such statements, reports, and other

documents, as are or may be required to continue such qualifications in effect for so long

a period as the Representative may reasonably request for distribution of the Warrants

and the Warrant Shares.


(vi)	The Company will deliver to, or upon the order of, the Representative or

the Selling Security Holder, from time to time, as many copies of any Preliminary

Prospectus and any Issuer Free Writing Prospectus as the Representative or the Selling

Security Holder, as the case may be, may reasonably request. The Company will deliver

to, or upon the order of, the Representative or the Selling Security Holder during the

period when delivery of a Prospectus (or, in lieu thereof, the notice referred to under Rule

173(a) under the Act) (the “Prospectus Delivery Period”) is required under the Act, as

many copies of the Prospectus in final form, or as thereafter amended or supplemented,

as the Representative or the Selling Security Holder, as the case may be, may reasonably

request.


(vii)	The Company will comply with the Act, the Exchange Act and the Rules

and Regulations, so as to permit the completion of the distribution of the Warrants and

the Warrant Shares as contemplated in this Agreement and the Prospectus. If during the

period in which a prospectus (or, in lieu thereof, the notice referred to under Rule 173(a)

under the Act) is required by law to be delivered by the Representative or any dealer any

event shall occur as a result of which, in the judgment of the Company, it becomes

necessary to amend or supplement the Prospectus in order to make the statements therein,

in the light of the circumstances existing at the time the Prospectus (or the notice referred

to above) is delivered to a purchaser, not misleading, or, if it is necessary at any time to

amend or supplement the Prospectus to comply with any law, the Company promptly will

either (i) prepare and file with the Commission an appropriate amendment to the

Registration Statement or supplement to the Prospectus or (ii) prepare and file with the

Commission an appropriate filing under the Exchange Act which shall be incorporated by

reference in the Prospectus so that the Prospectus as so amended or supplemented will

not, in the light of the circumstances when it (or such notice) is so delivered, be

misleading, or so that the Prospectus will comply with the law.


(viii)	If the General Disclosure Package is being used in connection with the

sale of the Warrants at a time when the Prospectus is not yet available to prospective

purchasers and any event shall occur as a result of which, in the judgment of the

Company, it becomes necessary to amend or supplement the General Disclosure Package

in order to make the statements therein, in the light of the circumstances existing at the

time, not misleading, or to make the statements therein not conflict with the information

contained in the Registration Statement then on file, or if it is necessary at any time to

amend or supplement the General Disclosure Package to comply with any law, the

Company promptly will either (i) prepare, file with the Commission (if required) and

furnish to the Representative and any dealers an appropriate amendment or supplement to

the General Disclosure Package or (ii) prepare and file with the Commission an

appropriate filing under the Exchange Act which shall be incorporated by reference in the

General Disclosure Package so that the General Disclosure Package as so amended or

supplemented will not, in the light of the circumstances existing at the time, be

misleading or conflict with the Registration Statement then on file, or so that the General

Disclosure Package will comply with law.


(ix)	The Company will make generally available to its security holders, as

soon as it is practicable to do so, but in any event not later than 15 months after the

effective date of the Registration Statement (as defined in Rule 158(c) under the Act), an

earnings statement (which need not be audited) in reasonable detail, complying with the

requirements of Section 11(a) of the Act and Rule 158 under the Act; provided that the

Company may make such earnings statement generally available by filing quarterly and

annual reports with the Commission as may be required by the Exchange Act.


(x)	No offering, sale, short sale or other disposition of any warrants or shares of

Common Stock of the Company or other securities convertible into or exchangeable or

exercisable for shares of Common Stock or derivative of Common Stock (or agreement for

such) will be made for a period of 45 days after the date of the Prospectus (such period, the

“Lockup Period”), directly or indirectly, by the Company otherwise than hereunder or with

the prior written consent of the Representative. Such restrictions shall not apply to (i) the

issuance by the Company of Common Stock or securities convertible into or exchangeable

for Common Stock in connection with the exercise of any option or warrant or the

conversion of a security outstanding on the date of this Agreement, (ii) the sale or

distribution by the Company of equity securities and/or options or other rights in respect

thereof solely registered on Form S-4 or S-8 (or any successor form), (iii) grants and

issuances by the Company of shares of equity securities and/or options or other rights in

respect thereof pursuant to stock-based compensation or incentive plans of the Company,

(iv) the issuance of shares of Common Stock in connection with dividend reinvestment

plans or employee stock purchase plans, and (v) issuances of shares of Common Stock in

connection with any court order or decree.


(xi)	The Company will use reasonable best efforts to effect and maintain,

subject to notice of issuance, the listing of the Warrant Shares issuable upon the exercise

of the Warrants on the Exchange and to maintain the listing of the Warrants on the

Exchange.


(xii)	The Company will reserve and keep available at all times, free of

preemptive or other similar rights, a sufficient number of shares of Common Stock for

the purpose of enabling the Company to satisfy any obligations to issue such shares upon

exercise of the Warrants.


(xiii)	The Company has caused each executive officer and director of the

Company identified on Schedule IV to furnish to you a letter or letters, dated the date

hereof, substantially in the form attached hereto as Exhibit B (the “Lockup Agreement”).


(xiv)	The Company will maintain a transfer agent and, if necessary under the

jurisdiction of incorporation of the Company, a registrar for the Warrants and for the

Common Stock.


(xv)	The Company will not take, directly or indirectly, any action designed to

cause or result in, or that has constituted or might reasonably be expected to constitute,

the stabilization or manipulation of the price of the Warrants or the Common Stock

excluding, for the avoidance of doubt, any bid for or purchase of Warrants made pursuant

to the process described in the General Disclosure Package.


(b)	The Selling Security Holder covenants and agrees with the several Underwriters

that it will not prepare or have prepared on its behalf or use or refer to, any “free writing

prospectus” (as defined in Rule 405 under the Act), and agrees that it will not distribute any

written materials in connection with the offer or sale of the Warrants without the prior approval

of the Representative.

5.COSTS AND EXPENSES.

The Company will pay all costs, expenses and fees incident to the performance of its

obligations under this Agreement and certain costs, expenses and fees of the Selling Security

Holder, including, without limiting the generality of the foregoing, the following: (i) accounting

fees of the Company; (ii) the fees and disbursements of counsel for the Company and the

reasonable fees and disbursements of Simpson Thacher & Bartlett LLP, counsel for Selling

Security Holder, not to exceed $25,000; (iii) any roadshow expenses; (iv) the cost of printing and

delivering to, or as requested by, the Representative copies of the Registration Statement,

Preliminary Prospectuses, the Issuer Free Writing Prospectuses, the Prospectus, this Agreement

and any supplements or amendments thereto; (v) the filing fees of the Commission; (vi) the filing

fees and expenses (including legal fees and disbursements) incident to securing any required

review by FINRA of the terms of the sale of the Warrants relating specifically to this offering of

Warrants; (vii) any listing fee of the Exchange with respect to the Warrants or the Warrant

Shares; and (viii) the expenses, including the reasonable fees and disbursements of Underwriter

Counsel (as defined herein), incurred in connection with the qualification of the Warrants and the

Warrant Shares under state securities or Blue Sky laws relating specifically to this offering of

Warrants. The Selling Security Holder will pay all costs, fees and expenses incident to the

performance of its obligations under this Agreement to the extent not paid by the Company.

Neither the Company nor the Selling Security Holder shall be required to pay for any

Underwriter’s expenses (other than those related to state securities or Blue Sky laws and

qualification under FINRA regulations) except that if this Agreement shall not be consummated

(a) because the conditions in Section 6 hereof (other than Section 6(b)) are not satisfied, (b)

because this Agreement is terminated by the Representative pursuant to Section 11(a)(i), (v) or

(vi) or Section 11(b) hereof, or (c) by reason of any failure, refusal or inability on the part of the

Company to perform any undertaking or satisfy any condition of this Agreement or to comply

with any of the terms hereof on their part to be performed, unless such failure, refusal or inability

is (1) due primarily to the default or omission of any Underwriter or (2) because the Selling

Security Holder is not selling any Warrants pursuant to Section 2(b) of this Agreement, then in

the case of any of (a), (b) or (c) the Company shall reimburse the several Underwriters for

reasonable out-of-pocket expenses, including fees and disbursements of counsel, reasonably

incurred in connection with investigating, marketing and proposing to market the Warrants or in

contemplation of performing their obligations hereunder; provided that the Company and the

Selling Security Holder shall not in any event be liable to the several Underwriters for damages

on account of loss of anticipated profits from the sale by them of the Warrants.

The provisions of this Section shall not supersede or otherwise affect any agreement that

the Company and the Selling Security Holder may otherwise have for the allocation of such

expenses between them.

6.CONDITIONS OF OBLIGATIONS OF THE UNDERWRITERS.

The several obligations of the Underwriters to purchase the Warrants on the Closing Date

are subject to the accuracy, as of the Applicable Time and the Closing Date, of the

representations and warranties of the Company and the Selling Security Holder contained herein,

and to the performance by the Company and the Selling Security Holder of its covenants and

obligations hereunder and to the following additional conditions:


(a)	The Preliminary Prospectus, the Prospectus and each Issuer Free Writing

Prospectus shall have been filed as required by Rules 424 (without reliance on Rule 424(b)(8)),

430A, 430B, 430C or 433 under the Act, as applicable, within the time period prescribed by, and

in compliance with, the Rules and Regulations, and any request of the Commission for additional

information (to be included in the Registration Statement or otherwise) shall have been disclosed

to the Representative and complied with to its reasonable satisfaction. No stop order suspending

the effectiveness of the Registration Statement, as amended from time to time, shall have been

issued, no proceedings for that purpose or pursuant to Section 8A under the Act shall have been

taken or, to the knowledge of the Company, shall be contemplated or threatened by the

Commission; no notice of objection of the Commission to the use of the Registration Statement

or any post-effective amendment thereto pursuant to Rule 401(g)(1) under the Act shall have

been received; and no injunction, restraining order or order of any nature by a Federal or state

court of competent jurisdiction shall have been issued as of the Closing Date which would

prevent the offer or sale of the Warrants.


(b)	The Selling Security Holder and the Representative shall have agreed to the

Clearing Price in writing.


(c)	The Representative shall have received on the Closing Date the opinion of

Goodwin Procter LLP, outside counsel for the Company (“Company Outside Counsel”), dated

the Closing Date, addressed to the Underwriters (and stating that it may be relied upon by

counsel to the Underwriters) in a form previously agreed upon.


(d)	The Representative shall have received on the Closing Date the opinion of the

General Counsel for the Company (“Company In-House Counsel”), dated the Closing Date,

addressed to the Underwriters (and stating that it may be relied upon by counsel to the

Underwriters) in a form previously agreed upon.


(e)	The Representative shall have received from Sullivan & Cromwell LLP, counsel

for the Underwriters (“Underwriter Counsel”), an opinion dated the Closing Date, in form and

substance reasonably satisfactory to the Representative, and such counsel shall have received

such documents and information as they may reasonably request to enable them to pass upon

such matters.


(f)	The Representative shall have received from Cleary Gottlieb Steen & Hamilton

LLP, an opinion dated the Closing Date, in form and substance reasonably satisfactory to the

Representative, and such counsel shall have received such documents and information as they

may reasonably request to enable them to pass upon such matters.


(g)	The Representative shall have received, on the date of this Agreement and on the

Closing Date, a letter dated such date in form and substance satisfactory to you, of the

Accountants confirming that they are an independent registered public accounting firm with

respect to the Company and the Subsidiaries within the meaning of the Act, the applicable Rules

and Regulations and the rules and regulations of the PCAOB and stating that in their opinion the

financial statements and schedules examined by them and included or incorporated by reference

in the Registration Statement, the General Disclosure Package and the Prospectus comply as to

form in all material respects with the applicable accounting requirements of the Act and the

related Rules and Regulations; and containing such other statements and information as is

ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial

statements and certain financial and statistical information contained in the Registration

Statement, the General Disclosure Package and the Prospectus.


(h)	The Representative shall have received, on the date of this Agreement and on the

Closing Date, a certificate dated such date and in form and substance satisfactory to you, of the

Chief Financial Officer of the Company.


(i)	The Representative shall have received on the Closing Date a certificate or

certificates of the Chief Executive Officer and the Chief Financial Officer of the Company to the

effect that, as of the Closing Date, each of them severally represents, to the best of his or her

knowledge, as follows:


(i)	The Registration Statement has become effective under the Act and no

stop order suspending the effectiveness of the Registration Statement or no order

preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing

Prospectus or the Prospectus has been issued, no proceedings for such purpose or

pursuant to Section 8A of the Act have been taken or are, to his or her knowledge,

contemplated or threatened by the Commission, and no notice of objection of the

Commission to the use of the Registration Statement or any post-effective amendment

thereto pursuant to Rule 401(g)(1) under the Act shall have been received;


(ii)	The representations and warranties of the Company contained in Section

1(a) hereof are true and correct as of the Closing Date;


(iii)	Since the respective dates as of which information is given in the

Registration Statement, the General Disclosure Package and Prospectus, and except as

otherwise publicly disclosed, there has not been any material adverse change in or

affecting the business, management, results of operations, or financial condition of the

Company and the Subsidiaries taken as a whole.


(j)	The Warrants and Warrant Shares have been approved for listing, subject to

notice of issuance, on the Exchange.


(k)	The Lockup Agreements have been executed and delivered.

The opinions and certificates mentioned in this Agreement shall be deemed to be in

compliance with the provisions hereof only if they are in all material respects reasonably

satisfactory to the Representative and to Underwriter Counsel.

If any of the conditions hereinabove provided for in this Section 6 shall not have been

fulfilled when and as required by this Agreement to be fulfilled, the obligations of the

Underwriters hereunder may be terminated by the Representative by notifying the Company and

the Selling Security Holder of such termination in writing at or prior to the Closing Date.

In such event, the Selling Security Holder, the Company and the Underwriters shall not be

under any obligation to each other (except to the extent provided in Sections 5 and 8 hereof).

7.CONDITIONS OF THE OBLIGATIONS OF THE SELLING SECURITY HOLDER.

The obligations of the Selling Security Holder to sell and deliver the Warrants required to

be delivered as and when specified in this Agreement are subject to the conditions that (a) at the

Closing Date no stop order suspending the effectiveness of the Registration Statement shall have

been issued and in effect or proceedings therefor initiated or threatened and (b) the Selling

Security Holder and the Representative shall have agreed to the Clearing Price in writing.

8.INDEMNIFICATION.


(a)	The Company agrees:


(i)	to indemnify and hold harmless each Underwriter, the directors and

officers of each Underwriter and each person, if any, who controls any Underwriter

within the meaning of either Section 15 of the Act or Section 20 of the Exchange Act,

against any losses, claims, damages or liabilities to which such Underwriter or any such

controlling person may become subject under the Act or otherwise, insofar as such losses,

claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of or

are based upon (i) any untrue statement or alleged untrue statement of any material fact

contained in the Registration Statement, any Preliminary Prospectus, any Issuer Free

Writing Prospectus, the General Disclosure Package, the Prospectus or any amendment

or supplement thereto, (ii) with respect to the Registration Statement or any amendment

or supplement thereto, the omission or alleged omission to state therein a material fact

required to be stated therein or necessary to make the statements therein not misleading

or (iii) with respect to any Preliminary Prospectus, any Issuer Free Writing Prospectus,

the General Disclosure Package, the Prospectus or any amendment or supplement thereto,

the omission or alleged omission to state therein a material fact required to be stated

therein or necessary to make the statements therein not misleading in the light of the

circumstances under which they were made; provided, however, that the Company will

not be liable in any such case to the extent that any such loss, claim, damage or liability

arises out of or is based upon an untrue statement or alleged untrue statement, or

omission or alleged omission made in the Registration Statement, any Preliminary

Prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package, the

Prospectus, or such amendment or supplement, in reliance upon and in conformity with

written information furnished to the Company by or through the Representative on behalf

of any Underwriters specifically for use therein, it being understood and agreed that the

only such information furnished by any Underwriter consists of the information described

as such in Section 13 herein; and


(ii)	to reimburse each Underwriter, each Underwriter’s directors and officers,

and each such controlling person of any of them upon demand for any legal or other outof-

pocket expenses reasonably incurred by such Underwriter or any of them in

connection with investigating or defending any such loss, claim, damage or liability,

action or proceeding or in responding to a subpoena or governmental inquiry related to

the offering of the Warrants, whether or not such Underwriter or any of them is a party to

any action or proceeding. In the event that it is finally judicially determined that the

Underwriters were not entitled to receive payments for legal and other expenses pursuant

to this subparagraph, the Underwriters will promptly return all sums that had been

advanced pursuant hereto.

This indemnity agreement will be in addition to any liability the Company may otherwise

have.


(b)	Each Underwriter, severally and not jointly, will indemnify and hold harmless the

Company, each of its directors, each of its officers who have signed the Registration Statement,

the Selling Security Holder, and each person, if any, who controls the Company or the Selling

Security Holder within the meaning of the Act, against any losses, claims, damages or liabilities

to which the Company or any such director, officer, Selling Security Holder or controlling

person may become subject under the Act or otherwise, insofar as such losses, claims, damages

or liabilities (or actions or proceedings in respect thereof) arise out of or are based upon (i) any

untrue statement or alleged untrue statement of any material fact contained in the Registration

Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the General

Disclosure Package, the Prospectus or any amendment or supplement thereto, or (ii) the omission

or alleged omission to state therein a material fact required to be stated therein or necessary to

make the statements therein not misleading in the light of the circumstances under which they

were made; and will reimburse any legal or other expenses reasonably incurred by the Company

or any such director, officer, Selling Security Holder or controlling person in connection with

investigating or defending any such loss, claim, damage, liability, action or proceeding;

provided, however, that each Underwriter will be liable in each case to the extent, but only to the

extent, that such untrue statement or alleged untrue statement or omission or alleged omission

has been made in the Registration Statement, any Preliminary Prospectus, any Issuer Free

Writing Prospectus, the General Disclosure Package, the Prospectus or such amendment or

supplement, in reliance upon and in conformity with written information furnished to the

Company by or through the Representative or on behalf of such Underwriter specifically for use

therein, it being understood and agreed that the only such information furnished by or on behalf

of any Underwriter consists of the information described as such in Section 13 herein. This

indemnity agreement will be in addition to any liability such Underwriter may otherwise have.


(c)	In case any proceeding (including any governmental investigation) shall be

instituted involving any person in respect of which indemnity may be sought pursuant to this

Section 8, such person (the “indemnified party”) shall promptly notify the person against whom

such indemnity may be sought (the “indemnifying party”) in writing. No indemnification

provided for in Section 8(a) or (b) shall be available to any party who shall fail to give notice as

provided in this Section 8(c) if the party to whom notice was not given was unaware of the

proceeding to which such notice would have related and was materially prejudiced by the failure

to give such notice, but the failure to give such notice shall not relieve the indemnifying party or

parties from any liability which it or they may have to the indemnified party for contribution or

otherwise than on account of the provisions of Section 8(a) or (b). In case any such proceeding

shall be brought against any indemnified party and it shall notify the indemnifying party of the

commencement thereof, the indemnifying party shall assume the defense thereof, including the

employment of counsel reasonably satisfactory to such indemnified party and payment of all fees

and expenses. The indemnified party or any such controlling person shall have the right to

employ separate counsel in any such action and participate in the defense thereof, but the fees

and expenses of such counsel shall be at the expense of the indemnified party or such controlling

person unless (i) the employment of such counsel shall have been specifically authorized in

writing by the indemnifying party, (ii) the indemnifying party shall have failed to assume the

defense and employ counsel or (iii) the named parties to any such action (including any

impleaded parties) include both the indemnified party or such controlling person and the

indemnifying party and the indemnified party or such controlling person shall have been advised

by such counsel that there may be one or more legal defenses available to it which are different

from or additional to those available to the indemnifying party (in which case the indemnifying

party shall not have the right to assume the defense of such action on behalf of the indemnified

party or such controlling person; provided, however, that the indemnifying party shall not, in

connection with any one such action or separate but substantially similar or related actions in the

same jurisdiction arising out of the same general allegations or circumstances, be liable for the

reasonable fees and expenses of more than one separate firm of attorneys (in addition to any

local counsel) for the indemnified party and controlling persons, which firm shall be designated

in writing by the indemnified party with respect to such action or actions. The indemnifying

party shall not be liable for any settlement of any proceeding effected without its written consent

but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying

party agrees to indemnify the indemnified party from and against any loss or liability by reason

of such settlement or judgment. In addition, the indemnifying party will not, without the prior

written consent of the indemnified party, settle or compromise or consent to the entry of any

judgment in any pending or threatened claim, action or proceeding of which indemnification may

be sought hereunder (whether or not any indemnified party is an actual or potential party to such

claim, action or proceeding) unless such settlement, compromise or consent includes an

unconditional release of each indemnified party from all liability arising out of such claim, action

or proceeding.


(d)	To the extent the indemnification provided for in this Section 8 is unavailable to

or insufficient to hold harmless an indemnified party under Section 8(a) or (b) above in respect

of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred

to therein, then each indemnifying party shall contribute to the amount paid or payable by such

indemnified party as a result of such losses, claims, damages or liabilities (or actions or

proceedings in respect thereof) in such proportion as is appropriate to reflect the relative benefits

received by the Company and the Selling Security Holder on the one hand and the Underwriters

on the other from the offering of the Warrants. If, however, the allocation provided by the

immediately preceding sentence is not permitted by applicable law then each indemnifying party

shall contribute to such amount paid or payable by such indemnified party in such proportion as

is appropriate to reflect not only such relative benefits but also the relative fault of the Company

and the Selling Security Holder on the one hand and the Underwriters on the other in connection

with the statements or omissions which resulted in such losses, claims, damages or liabilities (or

actions or proceedings in respect thereof), as well as any other relevant equitable considerations.

The relative benefits received by the Company and the Selling Security Holder on the one hand

and the Underwriters on the other shall be deemed to be in the same proportion as the total net

proceeds from the offering (before deducting expenses) received by the Selling Security Holder

bear to the total underwriting discounts and commissions received by the Underwriters, in each

case as set forth in the table on the cover page of the Prospectus. The relative fault shall be

determined by reference to, among other things, whether the untrue or alleged untrue statement

of a material fact or the omission or alleged omission to state a material fact relates to

information supplied by the Company or the Selling Security Holder on the one hand or the

Underwriters on the other and the parties’ relative intent, knowledge, access to information and

opportunity to correct or prevent such statement or omission.

The Company and the Underwriters agree that it would not be just and equitable if

contributions pursuant to this Section 8(d) were determined by pro rata allocation (even if the

Underwriters were treated as one entity for such purpose) or by any other method of allocation

which does not take account of the equitable considerations referred to above in this Section

8(d). The amount paid or payable by an indemnified party as a result of the losses, claims,

damages or liabilities (or actions or proceedings in respect thereof) referred to above in this

Section 8(d) shall be deemed to include any legal or other expenses reasonably incurred by such

indemnified party in connection with investigating or defending any such action or claim.

Notwithstanding the provisions of this Section 8(d), (i) no Underwriter shall be required to

contribute any amount in excess of the underwriting discounts and commissions applicable to the

Warrants purchased by such Underwriter and (ii) no person guilty of fraudulent

misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to

contribution from any person who was not guilty of such fraudulent misrepresentation.


(e)	Any expenses for which an indemnified party is entitled to indemnification or

contribution under this Section 8 shall be paid by the indemnifying party to the indemnified party

as such expenses are incurred. The indemnity and contribution agreements contained in this

Section 8 and the representations and warranties of the Company set forth in this Agreement

shall remain operative and in full force and effect, regardless of (i) any investigation made by or

on behalf of any Underwriter, its directors or officers or any person controlling any Underwriter,

the Company, its directors or officers or any persons controlling the Company, (ii) acceptance of

any Warrants and payment therefor hereunder, and (iii) any termination of this Agreement.


(f)	The provisions of this Section 8 shall not be deemed to supersede or otherwise

affect the Letter Agreement dated November 21, 2008 between the Company and the Selling

Security Holder (and the Securities Purchase Agreement Standard Terms incorporated therein),

pursuant to which the Selling Security Holder purchased the Warrants from the Company, with

respect to the rights (including the rights of their respective agents) and obligations of each of

them to the other pursuant thereto.


9.	DEFAULT BY UNDERWRITERS.

If on the Closing Date any Underwriter shall fail to purchase and pay for the portion of

the Warrants that Underwriter has agreed to purchase and pay for on such date (otherwise than

by reason of any default on the part of the Company or the Selling Security Holder), you, as

Representative, shall use your reasonable efforts to procure within 36 hours thereafter one or

more of the other Underwriters, or any others, to purchase from the Selling Security Holder, in

such amounts as may be agreed upon and upon the terms set forth herein, the Warrants the

defaulting Underwriter or Underwriters failed to purchase. If during such 36 hours you, as such

Representative, shall not have procured such other Underwriters, or any others, to purchase the

Warrants agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the

aggregate number of Warrants with respect to which such default shall occur does not exceed

10% of the Warrants to be purchased on the Closing Date, the other Underwriters shall be

obligated, severally, in proportion to the respective numbers of Warrants they are obligated to

purchase hereunder, to purchase the Warrants such defaulting Underwriter or Underwriters failed

to purchase, or (b) if the aggregate number of Warrants with respect to which such default shall

occur exceeds 10% of the Warrants to be purchased on the Closing Date, the Selling Security

Holder or you as the Representative will have the right, by written notice given within the next

36-hour period to the parties to this Agreement, to terminate this Agreement without liability on

the part of the non-defaulting Underwriters or of the Company or of the Selling Security Holder

except to the extent provided in Sections 5 and 8 hereof. In the event of a default by any

Underwriter or Underwriters, as set forth in this Section 9, the Closing Date may be postponed

for such period, not exceeding seven days, as you, as Representative, may determine in order that

the required changes in the Registration Statement, the General Disclosure Package or in the

Prospectus or in any other documents or arrangements may be effected. The term “Underwriter”

includes any person substituted for a defaulting Underwriter. Any action taken under this

Section 9 shall not relieve any defaulting Underwriter from liability in respect of any default of

such Underwriter under this Agreement

10.NOTICES.

All communications hereunder shall be in writing and, except as otherwise provided

herein, will be mailed, delivered, faxed, telecopied or telegraphed and confirmed as follows: if

to the Underwriters, to Deutsche Bank Securities Inc., 60 Wall Street, 4th Floor, New York, New

York 10005; Attention: Equity Capital Markets Syndicate Desk, with a copy to Deutsche Bank

Securities Inc., 60 Wall Street, New York, New York 10005, Attention: General Counsel; if to

the Selling Security Holder, to United States Department of the Treasury, 1500 Pennsylvania

Avenue, NW, Washington, D.C. 20220, with a copy to Chief Counsel, Office of Financial

Stability, OFSChiefCounselNotice@do.treas.gov, facsimile: 202-927-9219; and if to the

Company, to Boston Private Financial Holdings, Inc., Ten Post Office Square, Boston, MA

02109; Attention: General Counsel, with a copy to Goodwin Procter LLP, 53 State Street,

Boston, MA 02109; Attention: William P. Mayer and Paul W. Lee.

11.TERMINATION.

This Agreement may be terminated by the Representative by notice to the Company and

the Selling Security Holder (a) at any time prior to the Closing Date if any of the following has

occurred: (i) since the respective dates as of which information is given in the Registration

Statement, the General Disclosure Package and the Prospectus, any material adverse change or

any development involving a prospective material adverse change in or affecting the business,

management, operations or financial condition of the Company and the Subsidiaries taken as a

whole, whether or not arising in the ordinary course of business, (ii) any outbreak or escalation

of hostilities or declaration of war or national emergency or other national or international

calamity or crisis (including, without limitation, an act of terrorism) or change in economic or

political conditions if the effect of such outbreak, escalation, declaration, emergency, calamity,

crisis or change on the financial markets of the United States would, in your judgment, be so

material and adverse as to make it impractical or inadvisable to market the Warrants or enforce

contracts for the sale of the Warrants, (iii) suspension of trading in securities generally on the

Exchange or limitation on prices (other than limitations on hours or numbers of days of trading)

for securities on the Exchange, (iv) the declaration of a banking moratorium by United States or

New York State authorities, (v) any downgrading in the rating of any of the Company’s debt

securities by any “nationally recognized statistical rating organization” (as defined for purposes

of Rule 436(g) under the Exchange Act), or (vi) the suspension of trading of the Common Stock

by the Exchange, the Commission, or any other governmental authority; or (b) as provided in

Section 6 of this Agreement.


12.	SUCCESSORS.

This Agreement has been and is made solely for the benefit of the Underwriters, the

Company and the Selling Security Holder and their respective successors, executors,

administrators, heirs and assigns, and the officers, directors and controlling persons referred to

herein, and no other person will have any right or obligation hereunder. No purchaser of any of

the Warrants from any Underwriter shall be deemed a successor or assign merely because of

such purchase.


13.	INFORMATION PROVIDED BY UNDERWRITER.

The parties hereto acknowledge and agree that the only information furnished or to be

furnished by the Representative on behalf of the Underwriters to the Company for inclusion in

the Registration Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus or

the Prospectus consists of (i) the information contained in the section of the Preliminary

Prospectus entitled “Auction Process” and (ii) the information in the third paragraph, the third

sentence of the eighth paragraph, the first and third sentences of the ninth paragraph and the

second and third sentences of the tenth paragraph contained in the section of the Preliminary

Prospectus entitled “Underwriting.”


14.	MISCELLANEOUS.

The reimbursement, indemnification and contribution agreements contained in this

Agreement and the representations, warranties and covenants in this Agreement shall remain in

full force and effect regardless of (a) any termination of this Agreement, (b) any investigation

made by or on behalf of any Underwriter or controlling person thereof, or by or on behalf of the

Company or its directors or officers or the Selling Security Holder or controlling person thereof,

as the case may be, and (c) delivery of and payment for the Warrants under this Agreement.

The Company acknowledges and agrees that each Underwriter in providing investment

banking services to the Company or others in connection with the offering, including in acting

pursuant to the terms of this Agreement, has acted and is acting as an independent contractor and

not as a fiduciary, and the Company does not intend any Underwriter to act in any capacity other

than as an independent contractor, including as a fiduciary or in any other position of higher

trust.

This Agreement may be executed in two or more counterparts, each of which shall be

deemed an original, but all of which together shall constitute one and the same instrument.

This Agreement shall be governed by, and construed in accordance with, the law of the

State of New York, including, without limitation, Section 5-1401 of the New York General

Obligations Law.

The Underwriters, on the one hand, and the Company (on its own behalf and, to the

extent permitted by law, on behalf of its stockholders), on the other hand, waive any right to trial

by jury in any action, claim, suit or proceeding with respect to your engagement as underwriter

or your role in connection herewith.

If the foregoing letter is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicates hereof, whereupon it will become a binding agreement among the Selling Security Holder, the Company and the several Underwriters in accordance with its terms.


Very truly yours,
BOSTON PRIVATE FINANCIAL HOLDINGS, INC.


By	/s/ Margaret W. Chambers
	Name:	Margaret W. Chambers
	Title:	Executive Vice President, General
		Counsel and Secretary


UNITED STATES DEPARTMENT OF THE
TREASURY, as Selling Security Holder


By	/s/ Timothy G. Massad
	Name:	Timothy G. Massad
	Title:	Acting Assistant Secretary for
		Financial Stability

The foregoing Underwriting Agreement

is hereby confirmed and accepted as

of the date first above written.

DEUTSCHE BANK SECURITIES INC.

As Representative of the several Underwriters

listed on Schedule I

Signature Page to Underwriting Agreement


By:	Deutsche Bank Securities Inc.

By	/s/ Paul Stowell
	Authorized Officer


By	/s/ Neil Abromavage
	Authorized Officer

Signature Page to Underwriting Agreement

SCHEDULE I

Schedule of Underwriters


	Number of Warrants
Underwriter	to be Purchased

Deutsche Bank Securities Inc.

		2,887,500

Total		2,887,500

I-1

SCHEDULE II

Free Writing Prospectus dated January 31, 2011, filed by the Company pursuant to Rule 433 under the Act, describing the commencement time and certain other details of the Auction

II-1

SCHEDULE III

None

III-1

SCHEDULE IV

Clayton G. Deutsch

David J. Kaye

William A. Gratrix

Mark D. Thompson

James D. Dawson

Margaret W. Chambers

Martha T. Higgins

George L. Alexakos

Stephen M. Waters

Herbert S. Alexander

Eugene S. Colangelo

Adolfo Henriques

Lynn Thompson Hoffman

Deborah F. Kuenstner

John Morton III

William J. Shea

Allen L. Sinai

Timothy L. Vaill

IV-1

EXHIBIT A

Boston Private Bank & Trust Company

Borel Private Bank & Trust Company

First Private Bank & Trust

Charter Private Bank

Dalton, Greiner, Hartman, Maher & Co., LLC

Anchor Capital Holdings, LLC

KLS Professional Advisors Group, LLC

A-1

EXHIBIT B

Lock-Up Agreement

February 1, 2011

Boston Private Financial Holdings, Inc.

Ten Post Office Square

Boston, Massachusetts 02109

Deutsche Bank Securities Inc.

60 Wall Street, 4^th Floor

New York, New York 10005

Ladies and Gentlemen:

The undersigned understands that Deutsche Bank Securities Inc., as representative (the “Representative”) of the several underwriters (the “Underwriters”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Boston Private Financial Holdings, Inc. (the “Company”), and the United States Department of the Treasury (the “Selling Security Holder”) providing for the public offering (the “Public Offering”) by the Underwriters, including the Representative, of warrants (the “Warrants”) of the Company representing the right to purchase an aggregate of 2,887,500 shares of the Company's common stock, $1.00 par value (the “Common Stock”).

To induce the Underwriters to continue their efforts in connection with the Public Offering and pursuant to the terms of the Letter Agreement, dated November 21, 2008, between the Company and the Selling Security Holder, the undersigned agrees that, without the prior written consent of the Representative, the undersigned will not, directly or indirectly, offer, sell, pledge, contract to sell (including any short sale), grant any option to purchase or otherwise dispose of any warrants of the Company or shares of Common Stock (including, without limitation, shares of Common Stock of the Company which may be deemed to be beneficially owned by the undersigned on the date of the Underwriting Agreement in accordance with the rules and regulations of the Securities and Exchange Commission, shares of Common Stock which may be issued upon exercise of a stock option or warrant and any other security convertible into or exchangeable for Common Stock) or enter into any Hedging Transaction (as defined below) relating to such warrants or the Common Stock (each of the foregoing referred to as a “Disposition”) during the period specified in the following paragraph (the “Lock-Up Period”). The foregoing restriction is expressly intended to preclude the undersigned from engaging in any Hedging Transaction or other transaction which is designed to or reasonably expected to lead to or result in a Disposition during the Lock-Up Period even if the securities would be disposed of by someone other than the undersigned. “Hedging Transaction” means any short sale (whether or not against the box) or any purchase, sale or grant of any right (including, without limitation, any put or call option) with respect to any security that includes, relates to or derives any significant part of its value from the Common Stock (other than a broad-based market basket or index).

The Lock-Up Period will commence on the date of the Underwriting Agreement and continue until, and include, the date that is 45 days after the date of the final prospectus relating to the Public Offering.

Notwithstanding the foregoing, the undersigned may (a) (i) make pledges of Common Stock that existed prior to the date hereof, (ii) make re-pledges of Common Stock that was pledged pursuant to agreements that existed on the date hereof, or (iii) increase pledge amounts from those existing on the date

B-1

hereof, in each case to secure loans with financial institutions or sales or transfers by any pledgee of such Common Stock in accordance with the terms thereof, (b) transfer or otherwise dispose of (i) shares of Common Stock acquired in open market transactions by the undersigned after the settlement date of the Public Offering, and (ii) any or all of the shares of Common Stock or other Company securities if the transfer or other disposition is (A) by gift, will or other testamentary document or applicable laws of intestacy, (B) by distribution to partners, members or shareholders of entities controlled by the undersigned, to the undersigned's affiliates or to any investment fund or other entity controlled or managed by the undersigned, (C) by distribution to any charitable organization, family foundation or donor-advised fund at sponsoring organizations, (D) to a trust, including without exception, any grantor retained annuity trust, for the direct or indirect benefit of the undersigned or the immediate family member of the undersigned, or to any corporation, partnership, limited liability company or other entity all of the beneficial ownership interests of which are held by the undersigned or immediate family members of the undersigned, (E) pursuant to any 10b5-1 trading plan in effect prior to the date hereof, (F) by sale pursuant to the “cashless” exercise of stock options or vesting of restricted stock units to cover payment of the exercise price and/or tax withholding payments due upon exercise or vesting (including, to the extent such “cashless” transaction is not permitted, the sale of shares of Common Stock (whether issued upon such exercise or vesting of restricted stock units or previously held) with proceeds up to the amount of the exercise price and/or tax withholding payments made in connection with such exercise or vesting), (G) by exercise of stock options using shares of Common Stock previously owned for the exercise price and/or shares of Common Stock previously owned or share withholding for the tax withholding payments due upon exercise of such stock options, which may be pursuant to a 10b5-1 plan entered into on or after the date hereof, and (H) pursuant to a judicial decree and (c) enter into any new 10b5-1 plan, provided that no sales of Common Stock or other Company securities shall be made pursuant to such 10b5-1 plan until after the expiration of the Lock-Up Period; provided, however, that in the case of a transfer pursuant to clause (b)(ii)(A), (B), (C) and (D) above, it shall be a condition to the transfer that the transferee execute an agreement stating that the transferee is receiving and holding the securities subject to the provisions of this Lock-Up Agreement.

The undersigned hereby authorizes the Company and the transfer agent for the Company to decline to make any transfer of securities for which the undersigned is the record holder if such transfer would violate this Lock-Up Agreement.

In addition, the undersigned hereby waives any and all notice requirements and rights with respect to registration of securities pursuant to any agreement, understanding or otherwise setting forth the terms of any security of the Company held by the undersigned, including any registration rights agreement to which the undersigned and the Company may be party; provided that such waiver shall apply only to the proposed Public Offering, and any other action taken by the Company in connection with the proposed Public Offering.

The undersigned hereby agrees that, to the extent that the terms of this Lock-Up Agreement conflict with or are in any way inconsistent with any registration rights agreement to which the undersigned and the Company may be a party, this Lock-Up Agreement supersedes such registration rights agreement.

The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and any obligations of the undersigned shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned.

Notwithstanding anything herein to the contrary, if the closing of the Public Offering has not

B-2

occurred prior to the date two weeks after the date of this letter, this agreement shall be of no further force or effect.

Signature: ________________________________

Print Name: ______________________________

B-3

Attached files

Stock widget

Investing forum

BOSTON PRIVATE FINANCIAL HOLDINGS INC Reports